Intellective Biologics
Suzhou, China· Est.
A Chinese CDMO providing integrated biologics development and manufacturing services for monoclonal antibodies and ADCs.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A Chinese CDMO providing integrated biologics development and manufacturing services for monoclonal antibodies and ADCs.
OncologyImmunology
Technology Platform
Integrated biologics and antibody-drug conjugate (ADC) CDMO platform offering end-to-end services from cell line development through commercial-scale GMP manufacturing.
Opportunities
Capitalizing on the rapid growth of the ADC market and increasing outsourcing of biologics manufacturing by global biotechs, particularly those seeking cost-effective, large-scale capacity in China.
Risk Factors
Intense competition in the CDMO sector, potential regulatory complexities for cross-border projects, and execution risks associated with managing large-scale manufacturing operations for multiple clients.
Competitive Landscape
Competes with large global CDMOs (e.g., Lonza, Samsung Biologics) and domestic Chinese leaders (e.g., WuXi Biologics) by emphasizing speed, scale, and integrated end-to-end services for antibodies and ADCs.